Investigation of breast cancer stem cells in vitro by using IR spectroscopy
Abstract
Keywords
Kaynakça
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.
- Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2018; 68: 7–30.
- Chen K, Huang Y, Chen J. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin 2013; 34: 732–40.
- Palomeras S, Ruiz-Martínez S, Puig T. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance. Molecules 2018; 23: 2193.
- Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 2003; 100: 3983–8.
- Shetty G, Kendall C, Shepherd N, Stone N, Barr H. Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. Br J Cancer 2006; 94: 1460–4.
- Kumar S, Desmedt C, Larsimont D, Sotiriou C, Goormaghtigh E. Change in the microenvironment of breast cancer studied by FTIR imaging. Analyst 2013; 138: 4058–65.
- Güler G, Guven U, Oktem G. Characterization of CD133+/CD44+ human prostate cancer stem cells with ATR-FTIR spectroscopy. Analyst 2019; 144: 2138–49.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Günnur Güler
*
0000-0002-8485-7372
Türkiye
Ümmü Güven
0000-0002-5427-263X
Türkiye
Eda Açıkgöz
0000-0002-6772-3081
Türkiye
Gülperi Öktem
0000-0001-6227-9519
Türkiye
Yayımlanma Tarihi
30 Eylül 2020
Gönderilme Tarihi
4 Eylül 2019
Kabul Tarihi
2 Kasım 2019
Yayımlandığı Sayı
Yıl 1970 Cilt: 59 Sayı: 3